Martin “Marty” J. Landon has 30 years of experience in the health care industry. Landon has held senior positions in public and private companies and is recognized for building and leading high-performance teams and value-creating initiatives. In 2016, he joined BioBridge Global as chief executive officer. Landon serves on the board of the San Antonio Medical Foundation and as secretary/treasurer on the board of BioMed SA.
Landon began his career as an internal auditor at the University of Texas Health Science Center at San Antonio and later was an auditor for four years at public accounting firm Arthur Andersen & Co. In 1987, Landon joined lntelogic Trace, a NYSE-traded firm, where he was appointed chief financial officer.
From 1994 to 2012, Landon was an executive at Kinetic Concepts Inc., now Acelity, a global medical device company, where he led numerous acquisitions, financial and securities transactions. He developed major process improvements and IT initiatives that contributed to extraordinary growth, culminating in a $6.3 billion leveraged buyout. During his tenure at KCI, annual revenues increased from $250 million to nearly $2 billion.
Prior to his current role, Landon served as president and CEO of CeloNova BioSciences Inc., an early-stage, innovative medical device company that develops, manufactures and sells products with multiple vascular applications. Landon remains a member of the CeloNova board of directors.
Landon was a Certified Public Accountant from 1984 to 2010 and received his BA in accounting from Benedictine College in Kansas. Landon is a member of the advisory council of SAMMinistries in San Antonio, Texas, chair of the UTSA Research External Advisory Council and a member of the board of visitors at Southwestern University in Georgetown, Texas. He also serves as Chairman of the Board of Renovo Concepts Inc.
Read more
Dr. Beddard joined South Texas Blood & Tissue Center as the VP, Medical Affairs in August 2007. Prior to joining our organization, she worked for Johns Hopkins University as an Immunology Laboratory Research Associate, Tidewater Blood Research Laboratory, as the Medical Director, and Texas Cord Blood Bank, as the Medical Director.
Dr. Beddard received her undergraduate degree from the University of Virginia and her graduate degree from Eastern Virginia Medical School. She has licensures from Virginia, Texas, Georgia, and New York. She is also board certified in Clinical Pathology and Transfusion Medicine.
Read more
Granville has 30 years of experience in operations, manufacturing, services, quality, safety, and process improvement and has successfully guided teams across multiple global locations, driven revenue growth and ensured excellence in service delivery.
After graduating from Rensselaer Polytechnic Institute with a Bachelor of Science in Chemical Engineering, he worked for DuPont in Delaware and Mississippi before joining GE in 1990. He spent the next 24 years in GE working in its Plastics, Medical Systems, and Silicones businesses. He held many positions with GE of increasing complexity and responsibility. In 2014 he moved to Houston TX where he worked for Nexeo Solutions, InterWrap, Inc. and Gulf Coast Regional Blood Center before joining BioBridge Global in October 2017.
Read more
Becky Cap, a 25-year veteran of the life sciences industry, was named Senior Vice President, Business Development, BioBridge Global Advanced Therapies in October 2022. She has been with the organization since 2016 as Chief Operating Officer for GenCure.
In the newly created position, Cap works to build and maintain customer relationships, provide insight into the advanced therapies market, offer thought leadership in the space and collaborate with customers on custom solutions.
Cap, a Texas native, earned a bachelor’s degree from Harvard University and an MBA from Boston University’s Questrom School of Management. She began her career at Dana-Farber Cancer Institute in Boston, where she worked on early trials exploring the benefits of hematologic stem cell transplant for breast cancer and the effects of growth factors in high-dose chemotherapy trials.
Her move to industry began at Eidetics, a consulting firm focused on informing biomedical product development support. She supported US and global development and strategic marketing efforts for chemotherapeutics, leading monoclonal antibodies, tyrosine kinase inhibitors and immuno-oncology agents, including PD-1 and PDL-1 inhibitors. Her expertise was honed as oncology became an active and competitive market in which physicians and patients had multiple treatment options available to them for their cancers. She started one of the first oncology consulting practices in this strategic marketing and market research space. She also has run her own consulting firm and worked with a number of local startups in the San Antonio community.
Cap has provided strategic guidance for the development of pharmaceuticals and medical devices, both in large, established firms and early stage ventures. She has provided extensive entrepreneurial executive coaching and mentoring. She is an active member of local and national committees on regenerative medicine and cell therapy, two private company boards of directors and the Governing Committee for Seton Home. Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.
Read more
Mark Fite joined BioBridge Global in July 2020. He has been Chief Operating Officer for QualTex Laboratories since June 2021 and added responsibility for GenCure in October 2022. He brings more than 30 years of wide-ranging operations experience from a variety of biomedical and pharmaceutical organizations.
Fite’s most recent role was as Chief Operating Officer at Pharmaceutical Associates Inc., a generic liquid oral dose manufacturer focused on producing generic oral dose liquid bioequivalent formulations for children, adults and the elderly who may have swallowing disorders or restricted diets. Prior to that, Fite worked for 14 years for San Antonio-based DPT Laboratories. During his tenure at DPT as Senior Vice President for Operations, he was the project leader for multiple high-impact projects that allowed DPT to grow into a premier CDMO provider.
After graduating from Appalachian State University, Fite started his career at international health and beauty aid company Revlon, and then moved on to other management roles in the United States and the United Kingdom before joining DPT.
Read more
Scott Jones, PhD became Senior Vice President and Chief Scientific Officer of BioBridge Global in October 2022. He joined BioBridge Global in 1999 and has held various positions including Director and Vice President of Laboratory Services in 2004 and 2007 and Vice President, Scientific Affairs in 2012.
Jones’ expertise includes donor screening, cell and gene therapy testing, and analytical development. His work for BioBridge Global has included the development of multiple custom assays and products for applications in advanced therapies. He also has provided support for clinical trials, especially those required for FDA approval of assays and equipment. He was an important contributor to the establishment of the organization’s cGMP cellular therapy testing services, which include development of potency assays and other applications to support advanced therapies.
He has authored and delivered numerous oral and poster presentations at annual meetings for the Association for the Advancement of Blood & Biotherapies (AABB), the Congress of International Society of Blood Transfusion, the International Society for Cell & Gene Therapy (ISCT), and Phacilitate. He is also an active member of AABB, SCABB and ISCT.
Read more
Adrienne Blevins Mendoza became Senior Vice President with BioBridge Global and Chief Operating Officer (COO) for South Texas Blood & Tissue in January 2022. Prior to that, she served as Vice President of Blood Operations after transitioning in December 2020 from her role as Vice President of Global Quality for BioBridge Global.
She has more than 20 years of experience in quality systems and regulatory affairs, Lean 6-Sigma and strategic planning, and she has expertise in blood and blood components, cell-based therapies and human tissue products. Adrienne completed undergraduate studies in Business Administration at California Coast University and Biology at California State University, San Marcos. She pursued graduate studies in Administrative Leadership at University of Oklahoma and later completed executive leadership programs in Business Culture at Kellogg School of Management at Northwestern University. She holds a certificate in Healthcare Executive Leadership from the College of Human Ecology at Cornell University and has been nominated to the 2022 Harvard Business School's Young American Leaders Program. She enjoys team building, art, and music and loves spending time outdoors, camping and riding horses.
Read more
Richey Wyatt has an extensive legal background, first as a corporate attorney with the law firm Strasburger & Price, LLP (formerly Oppenheimer, Blend, Harrison and Tate, Inc.), where he was a partner and subsequently as Sr. Vice President and General Counsel for a group of health care related entrepreneurial ventures.
Richey received his undergraduate degree from Vanderbilt University (double majoring in English & Philosophy) and his law degree, with honors, from the University of Houston Law Center. Richey is very involved in the San Antonio community having served on various community and non-profit boards as well as in Leadership San Antonio (a leadership program jointly sponsored by the San Antonio Chamber of Commerce & the San Antonio Hispanic Chamber of Commerce). Richey is married to Joan and has two sons, Henry & Taylor.
Read more
John Youngdahl became Senior Vice President and Chief Financial Officer in July 2022. Prior to that, he served as Executive Director of Finance after transitioning in September 2021 from his role as Sr. Director of FP&A. John joined BioBridge Global in December 2016 and has more than 20 years of experience holding senior financial positions in finance, including roles in operations and marketing.
John earned his Bachelor of Arts degree in finance from Gustavus Adolphus College in St. Peter, Minnesota, and an MBA from Texas State University. He is a native of Texas and has had the good fortune of spending the majority of his life in Central and South Texas.
Read more
